Eris Lifesciences acquires trademark Zomelis (for Vildagliptin) from Novartis AG for India market EP News Bureau Dec 4, 2019 Zomelis is used in the treatment of type 2 diabetes and comes under a new class of anti-diabetic drugs known as DPP 4 inhibitors
